412 related articles for article (PubMed ID: 33172464)
21. Body mass index and the risk of recurrent coronary events following acute myocardial infarction.
Rea TD; Heckbert SR; Kaplan RC; Psaty BM; Smith NL; Lemaitre RN; Lin D
Am J Cardiol; 2001 Sep; 88(5):467-72. PubMed ID: 11524051
[TBL] [Abstract][Full Text] [Related]
22. The association between triglyceride-glucose index and major adverse cardiovascular events in patients with acute coronary syndrome - dose-response meta-analysis.
Akbar MR; Pranata R; Wibowo A; Irvan ; Sihite TA; Martha JW
Nutr Metab Cardiovasc Dis; 2021 Oct; 31(11):3024-3030. PubMed ID: 34625361
[TBL] [Abstract][Full Text] [Related]
23. Prevalence and in-hospital outcomes of diabetes among patients with acute coronary syndrome in China: findings from the Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome Project.
Zhou M; Liu J; Hao Y; Liu J; Huo Y; Smith SC; Ge J; Ma C; Han Y; Fonarow GC; Taubert KA; Morgan L; Yang N; Xing Y; Zhao D;
Cardiovasc Diabetol; 2018 Nov; 17(1):147. PubMed ID: 30482187
[TBL] [Abstract][Full Text] [Related]
24. Early and Chronic Dipeptidyl-Peptidase-IV Inhibition and Cardiovascular Events in Patients With Type 2 Diabetes Mellitus After an Acute Coronary Syndrome: A Landmark Analysis of the EXAMINE Trial.
Sharma A; Cannon CP; White WB; Liu Y; Bakris GL; Cushman WC; Zannad F
J Am Heart Assoc; 2018 May; 7(11):. PubMed ID: 29769203
[TBL] [Abstract][Full Text] [Related]
25. Reduction in the risk of major adverse cardiovascular events with the BET protein inhibitor apabetalone in patients with recent acute coronary syndrome, type 2 diabetes, and moderate to high likelihood of non-alcoholic fatty liver disease.
Toth PP; Schwartz GG; Nicholls SJ; Khan A; Szarek M; Ginsberg HN; Johansson JO; Kalantar-Zadeh K; Kulikowski E; Lebioda K; Wong NCW; Sweeney M; Ray KK;
Am J Prev Cardiol; 2022 Sep; 11():100372. PubMed ID: 36039183
[TBL] [Abstract][Full Text] [Related]
26. Early mortality and cardiovascular disease, varied association with body mass index and its changes in insulin-treated diabetes: a nationwide study.
Lee YB; Kim B; Park J; Kim M; Choi MS; Kim G; Jin SM; Hur KY; Han K; Kim JH
Int J Obes (Lond); 2021 Nov; 45(11):2482-2489. PubMed ID: 34344992
[TBL] [Abstract][Full Text] [Related]
27. Skeletal muscle mass in acute coronary syndrome prognosis: Gender-based analysis from Hellenic Heart Failure cohort.
Kouvari M; Chrysohoou C; Dilaveris P; Georgiopoulos G; Magkas N; Aggelopoulos P; Panagiotakos DB; Tousoulis D
Nutr Metab Cardiovasc Dis; 2019 Jul; 29(7):718-727. PubMed ID: 31151882
[TBL] [Abstract][Full Text] [Related]
28. Drinking patterns of alcohol and risk of major adverse cardiovascular events after an acute coronary syndrome.
Tessitore E; Branca M; Heg D; Nanchen D; Auer R; Räber L; Klingenberg R; Windecker S; Lüscher TF; Carballo S; Matter CM; Gmel G; Mukamal KJ; Rodondi N; Carballo D; Mach F; Gencer B
Eur J Prev Cardiol; 2024 May; 31(7):845-855. PubMed ID: 37995305
[TBL] [Abstract][Full Text] [Related]
29. Linagliptin and cardiovascular outcomes in type 2 diabetes after acute coronary syndrome or acute ischemic stroke.
Li YR; Tsai SS; Chen DY; Chen ST; Sun JH; Chang HY; Liou MJ; Chen TH
Cardiovasc Diabetol; 2018 Jan; 17(1):2. PubMed ID: 29301579
[TBL] [Abstract][Full Text] [Related]
30. The burden of major adverse cardiac events in patients with coronary artery disease.
Tsai IT; Wang CP; Lu YC; Hung WC; Wu CC; Lu LF; Chung FM; Hsu CC; Lee YJ; Yu TH
BMC Cardiovasc Disord; 2017 Jan; 17(1):1. PubMed ID: 28052754
[TBL] [Abstract][Full Text] [Related]
31. Antiplatelet treatment in diabetic patients with acute coronary syndrome undergoing percutaneous coronary intervention: a GReek AntiPlatElet registry substudy.
Hamilos M; Petousis S; Xanthopoulou I; Goudevenos J; Kanakakis J; Sitafidis G; Vavouranakis M; Skalidis E; Kochiadakis G; Lekakis J; Vardas PE; Alexopoulos D
Coron Artery Dis; 2018 Jan; 29(1):53-59. PubMed ID: 28834792
[TBL] [Abstract][Full Text] [Related]
32. Acute coronary syndrome in young women under 55 years of age: clinical characteristics, treatment, and outcomes.
Davis M; Diamond J; Montgomery D; Krishnan S; Eagle K; Jackson E
Clin Res Cardiol; 2015 Aug; 104(8):648-55. PubMed ID: 25687366
[TBL] [Abstract][Full Text] [Related]
33. Obesity Paradox in Off-Pump Coronary Artery Bypass Surgery: Does It Benefit the Elderly?
Badrudin D; Khaliel F; Cartier R
Ann Thorac Surg; 2016 Dec; 102(6):1974-1980. PubMed ID: 27372372
[TBL] [Abstract][Full Text] [Related]
34. The "overweight paradox" in the prognosis of acute coronary syndrome for patients with heart failure-A truth for all? A 10-year follow-up study.
Kouvari M; Chrysohoou C; Tsiamis E; Kosyfa H; Kalogirou L; Filippou A; Iosifidis S; Aggelopoulos P; Pitsavos C; Tousoulis D
Maturitas; 2017 Aug; 102():6-12. PubMed ID: 28610685
[TBL] [Abstract][Full Text] [Related]
35. Cardiovascular safety for once-weekly dulaglutide in type 2 diabetes: a pre-specified meta-analysis of prospectively adjudicated cardiovascular events.
Ferdinand KC; Botros FT; Atisso CM; Sager PT
Cardiovasc Diabetol; 2016 Feb; 15():38. PubMed ID: 26912057
[TBL] [Abstract][Full Text] [Related]
36. Association of body mass index with risk of acute myocardial infarction and mortality in Norwegian male and female patients with suspected stable angina pectoris: a prospective cohort study.
Borgeraas H; Hertel JK; Svingen GF; Seifert R; Pedersen EK; Schartum-Hansen H; Hjelmesæth J; Nygård O
BMC Cardiovasc Disord; 2014 May; 14():68. PubMed ID: 24885137
[TBL] [Abstract][Full Text] [Related]
37. Impact of triglyceride-glucose index on long-term cardiovascular outcomes in patients with myocardial infarction with nonobstructive coronary arteries.
Gao S; Ma W; Huang S; Lin X; Yu M
Nutr Metab Cardiovasc Dis; 2021 Oct; 31(11):3184-3192. PubMed ID: 34511291
[TBL] [Abstract][Full Text] [Related]
38. Obesity paradox in Korean male and female patients with heart failure: A report from the Korean Heart Failure Registry.
Lee SY; Kim HL; Kim MA; Park JJ; Choi DJ; Kim JJ; Jeon ES; Cho MC
Int J Cardiol; 2021 Feb; 325():82-88. PubMed ID: 33045277
[TBL] [Abstract][Full Text] [Related]
39. Dapagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Previous Myocardial Infarction.
Furtado RHM; Bonaca MP; Raz I; Zelniker TA; Mosenzon O; Cahn A; Kuder J; Murphy SA; Bhatt DL; Leiter LA; McGuire DK; Wilding JPH; Ruff CT; Nicolau JC; Gause-Nilsson IAM; Fredriksson M; Langkilde AM; Sabatine MS; Wiviott SD
Circulation; 2019 May; 139(22):2516-2527. PubMed ID: 30882239
[TBL] [Abstract][Full Text] [Related]
40. Hospitalization for heart failure incidence according to the transition in metabolic health and obesity status: a nationwide population-based study.
Lee YB; Kim DH; Kim SM; Kim NH; Choi KM; Baik SH; Park YG; Han K; Yoo HJ
Cardiovasc Diabetol; 2020 Jun; 19(1):77. PubMed ID: 32534576
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
